(Q48498634)

12 February 2018

title

Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma. (English)

1 reference

12 February 2018

0 references

1 reference

Makoto Hoshino

1

1 reference

12 February 2018

Junichi Ohtawa

series ordinal

2

1 reference

12 February 2018

publication date

11 January 2012

1 reference

12 February 2018

published in

Respiration

1 reference

12 February 2018

volume

83

1 reference

12 February 2018

issue

6

1 reference

12 February 2018

page(s)

520-528

1 reference

12 February 2018

Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases

cites work

1 reference

Molecular and cellular targets of anti-IgE antibodies

21 January 2018

1 reference

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression

21 January 2018

1 reference

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

21 January 2018

1 reference

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

21 January 2018

1 reference

Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.

21 January 2018

1 reference

Safety and tolerability of omalizumab

21 January 2018

1 reference

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

21 January 2018

1 reference

Airway remodeling in asthma: new insights

21 January 2018

1 reference

Airway remodeling contributes to the progressive loss of lung function in asthma: an overview

21 January 2018

1 reference

High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity

21 January 2018

1 reference

Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning

21 January 2018

1 reference

Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma

21 January 2018

1 reference

Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.

21 January 2018

1 reference

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma

21 January 2018

1 reference

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

21 January 2018

1 reference

The prediction of small airway dimensions using computed tomography

21 January 2018

1 reference

Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects

21 January 2018

1 reference

Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.

21 January 2018

1 reference

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

21 January 2018

1 reference

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

21 January 2018

1 reference

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma

21 January 2018

1 reference

Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment

21 January 2018

1 reference

Multidetector row computed tomography to assess changes in airways linked to asthma control.

21 January 2018

1 reference

21 January 2018

1 reference

Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma

21 January 2018

1 reference

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

21 January 2018

1 reference

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma

21 January 2018

1 reference

Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model

21 January 2018

1 reference

Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334701

1 reference

12 February 2018

1 reference

12 February 2018